Sanofi Consumer Healthcare Stock Screener | Share Price & Fundamental Analysis
SANOFICONR
Pharmaceuticals
Screen Sanofi Consumer Healthcare share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹4464.10
▲
64.60 (1.47%)
Share Price BSE
₹4467.30
▲
77.70 (1.77%)
Market Cap
₹10,504.96 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
40.56
EPS (TTM)
₹78.59
Dividend Yield
1.21%
Debt to Equity
0.04
52W High
₹5696.00
52W Low
₹4399.50
Operating Margin
35.00%
Profit Margin
26.46%
Revenue (TTM)
₹824.00
EBITDA
₹304.00
Net Income
₹218.00
Total Assets
₹431.00
Total Equity
₹273.00
Sanofi Consumer Healthcare Share Price History - Stock Screener Chart
Screen SANOFICONR historical share price movements with interactive charts. Analyze price trends and patterns.
Sanofi Consumer Healthcare Company Profile - Fundamental Screener
Screen Sanofi Consumer Healthcare company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SANOFICONR shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0UOS01011
Sanofi Consumer Healthcare Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen SANOFICONR balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2024 | 2023 |
|---|---|---|
| Assets | ||
| Total Assets | 431 | 345 |
| Current Assets | 392 | 335 |
| Fixed Assets | 29 | 5 |
| Liabilities | ||
| Total Liabilities | 431 | 345 |
| Current Liabilities | 28 | 8 |
| Non-Current Liabilities | 0 | 0 |
| Shareholders' Equity | ||
| Total Equity | 273 | 208 |
| Share Capital | 23 | 2 |
| Reserves & Surplus | 250 | 183 |
Screen SANOFICONR income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | None-None | 2024-March | 2023-March |
|---|---|---|---|
| Revenue | 824 | 738 | 560 |
| Expenses | 520 | 454 | 337 |
| EBITDA | 304 | 284 | 223 |
| Operating Profit % | 35.00% | 37.00% | 39.00% |
| Depreciation | 9 | 5 | 2 |
| Interest | 2 | 4 | 0 |
| Profit Before Tax | 293 | 247 | 219 |
| Tax | 76 | 66 | 54 |
| Net Profit | 218 | 181 | 165 |
| EPS | 94.60 | 78.59 | 71.60 |
Sanofi Consumer Healthcare Cash Flow Screener - Liquidity Fundamentals
Screen SANOFICONR cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2024-March | 2023-March |
|---|---|---|
| Operating Activities | 439 | 0 |
| Investing Activities | 2 | 0 |
| Financing Activities | -116 | 2 |
| Net Cash Flow | 325 | 2 |
Screen SANOFICONR shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Jun | 2024-Sept | 2024-Oct | 2024-Dec |
|---|---|---|---|---|---|---|---|
| Promoter Holding | 60.40% | 71.27% | 71.27% | 60.40% | 60.40% | 60.40% | 60.40% |
| FII Holding | 4.53% | 3.24% | 2.94% | 0.00% | 5.22% | 4.87% | 4.42% |
| DII Holding | 25.48% | 16.89% | 17.21% | 20.87% | 24.03% | 24.51% | 25.35% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 6.58% | 6.30% | 6.26% | 7.71% | 7.53% | 7.41% | 7.01% |
| Other Holding | 3.01% | 2.30% | 2.32% | 11.03% | 2.83% | 2.82% | 2.83% |
| Shareholder Count | 51,859 | 49,632 | 48,808 | 61,091 | 61,091 | 57,598 | 55,734 |
Sanofi Consumer Healthcare Dividend Screener - Share Yield Analysis
Screen SANOFICONR dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹55.00 | 1.14% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Sanofi Consumer Healthcare Index Membership - Market Screener Classification
Screen SANOFICONR by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Sanofi Consumer Healthcare Market Events Screener - Corporate Actions
Screen SANOFICONR market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -5.60% |
| 2025-08-04 | 2025-08-04 | Quarterly Result Announcement | NA | -2.10% |
| 2025-05-05 | 2025-05-05 | Annual General Meeting | NA | 3.96% |
| 2025-05-02 | 2025-05-02 | Quarterly Result Announcement | NA | 0.05% |
| 2025-04-17 | 2025-04-17 | Dividend | ₹ 55.00 /share | 5.07% |
| 2025-02-20 | 2025-02-20 | Quarterly Result Announcement | NA | 0.62% |
| 2024-11-12 | 2024-11-12 | Quarterly Result Announcement | NA | 0.97% |
Sanofi Consumer Healthcare Competitors Screener - Peer Comparison
Screen SANOFICONR competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 412,950 | 39.35 | 54,729 | 9.71% | 10,980 | 39.47 |
| Divis Laboratories | 168,413 | 68.31 | 9,712 | 18.67% | 2,191 | 44.14 |
| Torrent Pharmaceuticals | 130,247 | 60.76 | 11,539 | 6.99% | 1,911 | 62.90 |
| Cipla | 121,238 | 22.46 | 28,410 | 7.12% | 5,291 | 46.90 |
| Dr Reddys Laboratories | 104,613 | 18.49 | 33,741 | 16.73% | 5,725 | 43.77 |
| Lupin | 96,056 | 22.19 | 22,910 | 13.74% | 3,306 | 55.44 |
| Zydus Life Science | 92,075 | 18.30 | 23,511 | 18.55% | 4,615 | 44.07 |
| Mankind Pharma | 89,356 | 51.11 | 12,744 | 20.90% | 2,007 | 44.20 |
| Aurobindo Pharma | 69,290 | 20.05 | 32,346 | 9.43% | 3,484 | 49.09 |
| Alkem Laboratories | 65,324 | 27.31 | 13,458 | 3.70% | 2,216 | 38.49 |
Sanofi Consumer Healthcare Company Announcements - News Screener
Screen SANOFICONR latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-01-01 | Closure of Trading Window | View |
| 2025-11-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-11-12 | Results-Financial Results For September 30 2025 | View |
| 2025-11-12 | Board Meeting Outcome for Outcome Of Board Meeting Held On Wednesday 12Th November 2025 | View |
| 2025-11-05 | Board Meeting Intimation for Board Meeting Intimation For Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 30Th September 2025 | View |
| 2025-10-30 | Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot | View |
| 2025-10-30 | Shareholder Meeting / Postal Ballot-Scrutinizer"s Report | View |
| 2025-10-16 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-10-10 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-10 | Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO) | View |
| 2025-09-30 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-01 | Announcement under Regulation 30 (LODR)-Change in Management | View |
| 2025-08-06 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-08-04 | Appointment Of Chief Financial Officer - Key Managerial Personnel | View |
| 2025-08-04 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | View |
| 2025-08-04 | Outcome Of Board Meeting Held On Monday 4Th August 2025 | View |
| 2025-08-04 | Board Meeting Outcome for Outcome Of Board Meeting Held On Monday 4Th August 2025 | View |